Beyond the finish line - Dr Andrew Rut in PharmaTimes

Beyond the finish line - Dr Andrew Rut in PharmaTimes


Dr Andrew Rut in PharmaTimes magazine - January 2021

How can pharma help drive COVID-19 vaccination adherence?

The authorisation of Pfizer/BioNTech, Moderna and now Oxford/AstraZeneca COVID-19 vaccines has brought much needed hope in the face of rapidly rising COVID-19 infection rates around the world. It is a truly remarkable achievement that the pharmaceutical industry has transformed its drug discovery and development to launch vaccines in less than 12 months and deliver headline efficacy rates of circa 95%.

However, market authorisation is simply one leg in a relay race. The next stage will be managing the wave of information requests and safety reports that must be expected as part of the COVID-19 mass vaccination campaigns...

Click here to read the full article in PharmaTimes

Request More Information

To find out more or request a demo fill in the details below:

By submitting your information, you are consenting to receive communications from MyMeds&Me. You may at any time 'opt out' of receiving these marketing communications by emailing


We use analytical cookies that need your permission. For more details and advanced options view our Cookies Policy.